Founded in 1985, it has developed prominence in both research and education in biotechnology. The center emphasizes a fundamental but interdisciplinary approach to integrating molecular and cell biology with process engineering with the simultaneous goals of creating advanced biological technologies, focusing on protein and nucleic acid therapeutics, and preparing top-quality individuals for leadership in this industry. The drug firms have jointly funded new research projects that address product and process improvements through innovation in pharmaceutical manufacturing. Beyond the campuses, the Boston area is a haven both for clinical medicine and high-technology businesses related to biomedicine. Applicants will be mature professionals with scientific or technical backgrounds and with work experience beyond university education in the biomedical field.
Preference is given to applicants sponsored by their employer organizations.
For specific information on admissions requirements and the application process, please refer to the MIT Management of Technology Program brochure for 2000-01.